Detalhe da pesquisa
1.
Assessment of Temporary Warfarin Reversal in Patients With Left Ventricular Assist Devices: the KVAD Study.
J Card Fail
; 2024 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38521486
2.
Avatrombopag for adults with early versus chronic immune thrombocytopenia.
Am J Hematol
; 99(2): 155-162, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38063420
3.
Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT.
Circulation
; 146(18): 1344-1356, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36036760
4.
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction.
Oncologist
; 28(7): 555-564, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171998
5.
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
N Engl J Med
; 382(17): 1599-1607, 2020 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32223112
6.
What Role Does Microthrombosis Play in Long COVID?
Semin Thromb Hemost
; 2023 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37748518
7.
Clinically stable covid-19 patients presenting to acute unscheduled episodic care venues have increased risk of hospitalization: secondary analysis of a randomized control trial.
BMC Infect Dis
; 23(1): 325, 2023 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37189091
8.
Thrombosis-Related Loss of Arterial Lines in the First Wave of COVID-19 and Non-COVID-19 Intensive Care Unit Patients.
Anesth Analg
; 136(1): 70-78, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219579
9.
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.
JAMA
; 329(22): 1924-1933, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37266947
10.
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.
JAMA
; 330(22): 2171-2181, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950897
11.
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
Lancet Oncol
; 23(7): e334-e347, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772465
12.
COVID-19 and its implications for thrombosis and anticoagulation.
Blood
; 135(23): 2033-2040, 2020 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32339221
13.
Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial
Haematologica
; 107(7): 1567-1576, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382385
14.
Activated Clotting Times Demonstrate Weak Correlation With Heparin Dosing in Adult Extracorporeal Membrane Oxygenation.
Am J Ther
; 29(4): e385-e393, 2022 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31833874
15.
Evaluation of the use of direct oral anticoagulants for the management of heparin-induced thrombocytopenia.
J Thromb Thrombolysis
; 54(4): 597-604, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129561
16.
Approach to Cancer-Associated Thrombosis: Challenging Situations and Knowledge Gaps.
Oncologist
; 26(1): e17-e23, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275323
17.
Update on Guidelines for the Management of Cancer-Associated Thrombosis.
Oncologist
; 26(1): e24-e40, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275332
18.
Prediction and Prevention of Cancer-Associated Thromboembolism.
Oncologist
; 26(1): e2-e7, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274815
19.
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
Oncologist
; 26(1): e8-e16, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275319
20.
Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation.
N Engl J Med
; 379(19): 1846-1850, 2018 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30403942